Corix Bioscience (Corix Bioscience) EV-to-EBITDA : 0.00 (As of Jun. 18, 2024)

Corix Bioscience EV-to-EBITDA Chart

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
EV-to-EBITDA	Get a 7-Day Free Trial															-10.48	-3.59	-3.16	-3.94	-4.58

Competitive Comparison of Corix Bioscience's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's EV-to-EBITDA falls into.

Corix Bioscience EV-to-EBITDA Calculation

Corix Bioscience's EV-to-EBITDA for today is calculated as:

Corix Bioscience's current Enterprise Value is $0.00 Mil.
Corix Bioscience's EBITDA for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience  (GREY:CXBS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Corix Bioscience's PE Ratio for today is calculated as:

Corix Bioscience's share price for today is $0.0001.
Corix Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.290.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Corix Bioscience EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description